Tvardi Therapeutics, Inc. Made Headway
Tue, Jul 07, 2026 at 07:46 PM
Tvardi Therapeutics, Inc. (TVRD:NASDAQ) rocketted at $3.1, representing a gain of 54.2%. On Tue, Jul 07, 2026, TVRD:NASDAQ touched a New 2-Week High of $3.1. The stock appeared on our News Catalysts scanner on Tue, Jul 07, 2026 at 09:16 AM in the 'BIOTECH' category. From Tue, Jun 23, 2026, the stock recorded 55.56% Up Days and 60.00% Green Days
About Tvardi Therapeutics, Inc. (TVRD:NASDAQ)
Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 287.5%
- Crinetics Pharmaceuticals, Inc. (CRNX:NASDAQ), 98.74%
- ClearOne, Inc. (CLRO:NASDAQ), 97.71%
- Tvardi Therapeutics, Inc. (TVRD:NASDAQ), 54.23%
- The Beauty Health Company (SKIN:NASDAQ), 47.04%
- Akari Therapeutics, Plc (AKTX:NASDAQ), 42.02%
- Sky Quarry Inc. (SKYQ:NASDAQ), 41.51%
- Trident Digital Tech Holdings Ltd (TDTH:NASDAQ), 40.66%
- Veraxa Biotech AG (VRXA:NASDAQ), 38.36%
- Turn Therapeutics Inc. (TTRX:NASDAQ), 26.27%